University that employed a controversial herpes vaccine researcher says it learned about his illegal experimentation on human subjects, last summer.
Genomic data can have a significant effect on other areas of society. Insurance premiums, familial impact, identification. As we enter the genomic era, policy will need to reflect these new considerations.
Drugmakers, hospitals and lawmakers are taking sides in a showdown over a discount program that covers drug purchases at some hospitals.
Ahead of Brexit, the government are pushing for growth in the pharma sector through investments in R&D, and infrastructure.
Sir John Chisholm, Executive Chair of Genomics England responds to policy paper from the UK government.
The FDA has released new guidelines in a bid to quicken the implementation of treatments involving human cells and tissues, including gene therapy.
George Church has published an opinion article today which argues that gene editing within the human germline should not be rejected out of hand
Laws passed by many states that require health plans to charge the same cost-sharing amounts for cancer patients receiving chemotherapy are proving uneven.
Medicaid is rarely associated with getting rich, but somehow insurers make billions off it in California during Obamacare expansion.